Herpes Simplex Virus 1 Induces Cytoplasmic Accumulation of TIA-1/TIAR and both Synthesis and Cytoplasmic Accumulation of Tristetraprolin, Two Cellular Proteins That Bind and Destabilize AU-Rich RNAs

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published inJournal of Virology Vol. 78; no. 16; pp. 8582 - 8592
Main Authors Esclatine, Audrey, Taddeo, Brunella, Roizman, Bernard
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.08.2004
Subjects
Biological and medical sciences
Cell Line, Tumor
Cells, Cultured
Cytoplasm - metabolism
DNA-Binding Proteins
Fibroblasts - virology
Fundamental and applied biological sciences. Psychology
HeLa Cells
Herpes simplex virus 1
Herpesvirus 1, Human - pathogenicity
Human viral diseases
Humans
Immediate-Early Proteins - genetics
Immediate-Early Proteins - metabolism
Infectious diseases
Medical sciences
Microbiology
Miscellaneous
Poly(A)-Binding Proteins
Proteins - genetics
Proteins - metabolism
Ribonucleases
RNA, Messenger - genetics
RNA, Messenger - metabolism
RNA-Binding Proteins - genetics
RNA-Binding Proteins - metabolism
T-Cell Intracellular Antigen-1
Tristetraprolin
Up-Regulation
Viral diseases
Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye
Viral Proteins - metabolism
Virology
Virus-Cell Interactions
Microbiology
RNA
Herpesviridae
Alphaherpesvirinae
Herpes
Protein
Virology
Infection
Virus
Synthesis
Viral disease
Human herpesvirus 1
Herpesvirus hominis
Online AccessGet full text

Cover

Abstract Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
AbstractList Herpes simplex virus 1 causes a shutoff of cellular protein synthesis through the degradation of RNA that is mediated by the virion host shutoff (Vhs) protein encoded by the U(L)41 gene. We reported elsewhere that the Vhs-dependent degradation of RNA is selective, and we identified RNAs containing AU-rich elements (AREs) that were upregulated after infection but degraded by deadenylation and progressive 3'-to-5' degradation. We also identified upregulated RNAs that were not subject to Vhs-dependent degradation (A. Esclatine, B. Taddeo, L. Evans, and B. Roizman, Proc. Natl. Acad. Sci. USA 101:3603-3608, 2004). Among the latter was the RNA encoding tristetraprolin, a protein that binds AREs and is known to be associated with the degradation of RNAs containing AREs. Prompted by this observation, we examined the status of the ARE binding proteins tristetraprolin and TIA-1/TIAR in infected cells. We report that tristetraprolin was made and accumulated in the cytoplasm of wild-type virus-infected human foreskin fibroblasts as early as 2 h and in HEp-2 cells as early as 6 h after infection. The amounts of tristetraprolin that accumulated in the cytoplasm of cells infected with a mutant virus lacking U(L)41 were significantly lower than those in wild-type virus-infected cells. The localization of tristetraprolin was not modified in cells infected with a mutant lacking the gene encoding infected cell protein 4 (ICP4). TIA-1 and TIAR are two other proteins that are associated with the regulation of ARE-containing RNAs and that normally reside in nuclei. In infected cells, they started to accumulate in the cytoplasm after 6 h of infection. In cells infected with the mutant virus lacking U(L)41, TIA-1/TIAR accumulated in the cytoplasm in granular structures reminiscent of stress granules in a significant percentage of the cells. In addition, an antibody to tristetraprolin coprecipitated the Vhs protein from lysates of cells late in infection. The results indicate that the Vhs-dependent degradation of ARE-containing RNAs correlates with the transactivation, cytoplasmic accumulation, and persistence of tristetraprolin in infected cells.Herpes simplex virus 1 causes a shutoff of cellular protein synthesis through the degradation of RNA that is mediated by the virion host shutoff (Vhs) protein encoded by the U(L)41 gene. We reported elsewhere that the Vhs-dependent degradation of RNA is selective, and we identified RNAs containing AU-rich elements (AREs) that were upregulated after infection but degraded by deadenylation and progressive 3'-to-5' degradation. We also identified upregulated RNAs that were not subject to Vhs-dependent degradation (A. Esclatine, B. Taddeo, L. Evans, and B. Roizman, Proc. Natl. Acad. Sci. USA 101:3603-3608, 2004). Among the latter was the RNA encoding tristetraprolin, a protein that binds AREs and is known to be associated with the degradation of RNAs containing AREs. Prompted by this observation, we examined the status of the ARE binding proteins tristetraprolin and TIA-1/TIAR in infected cells. We report that tristetraprolin was made and accumulated in the cytoplasm of wild-type virus-infected human foreskin fibroblasts as early as 2 h and in HEp-2 cells as early as 6 h after infection. The amounts of tristetraprolin that accumulated in the cytoplasm of cells infected with a mutant virus lacking U(L)41 were significantly lower than those in wild-type virus-infected cells. The localization of tristetraprolin was not modified in cells infected with a mutant lacking the gene encoding infected cell protein 4 (ICP4). TIA-1 and TIAR are two other proteins that are associated with the regulation of ARE-containing RNAs and that normally reside in nuclei. In infected cells, they started to accumulate in the cytoplasm after 6 h of infection. In cells infected with the mutant virus lacking U(L)41, TIA-1/TIAR accumulated in the cytoplasm in granular structures reminiscent of stress granules in a significant percentage of the cells. In addition, an antibody to tristetraprolin coprecipitated the Vhs protein from lysates of cells late in infection. The results indicate that the Vhs-dependent degradation of ARE-containing RNAs correlates with the transactivation, cytoplasmic accumulation, and persistence of tristetraprolin in infected cells.
Herpes simplex virus 1 causes a shutoff of cellular protein synthesis through the degradation of RNA that is mediated by the virion host shutoff (Vhs) protein encoded by the U L 41 gene. We reported elsewhere that the Vhs-dependent degradation of RNA is selective, and we identified RNAs containing AU-rich elements (AREs) that were upregulated after infection but degraded by deadenylation and progressive 3′-to-5′ degradation. We also identified upregulated RNAs that were not subject to Vhs-dependent degradation (A. Esclatine, B. Taddeo, L. Evans, and B. Roizman, Proc. Natl. Acad. Sci. USA 101:3603-3608, 2004). Among the latter was the RNA encoding tristetraprolin, a protein that binds AREs and is known to be associated with the degradation of RNAs containing AREs. Prompted by this observation, we examined the status of the ARE binding proteins tristetraprolin and TIA-1/TIAR in infected cells. We report that tristetraprolin was made and accumulated in the cytoplasm of wild-type virus-infected human foreskin fibroblasts as early as 2 h and in HEp-2 cells as early as 6 h after infection. The amounts of tristetraprolin that accumulated in the cytoplasm of cells infected with a mutant virus lacking U L 41 were significantly lower than those in wild-type virus-infected cells. The localization of tristetraprolin was not modified in cells infected with a mutant lacking the gene encoding infected cell protein 4 (ICP4). TIA-1 and TIAR are two other proteins that are associated with the regulation of ARE-containing RNAs and that normally reside in nuclei. In infected cells, they started to accumulate in the cytoplasm after 6 h of infection. In cells infected with the mutant virus lacking U L 41, TIA-1/TIAR accumulated in the cytoplasm in granular structures reminiscent of stress granules in a significant percentage of the cells. In addition, an antibody to tristetraprolin coprecipitated the Vhs protein from lysates of cells late in infection. The results indicate that the Vhs-dependent degradation of ARE-containing RNAs correlates with the transactivation, cytoplasmic accumulation, and persistence of tristetraprolin in infected cells.
Herpes simplex virus 1 causes a shutoff of cellular protein synthesis through the degradation of RNA that is mediated by the virion host shutoff (Vhs) protein encoded by the U(L)41 gene. We reported elsewhere that the Vhs-dependent degradation of RNA is selective, and we identified RNAs containing AU-rich elements (AREs) that were upregulated after infection but degraded by deadenylation and progressive 3'-to-5' degradation. We also identified upregulated RNAs that were not subject to Vhs-dependent degradation (A. Esclatine, B. Taddeo, L. Evans, and B. Roizman, Proc. Natl. Acad. Sci. USA 101:3603-3608, 2004). Among the latter was the RNA encoding tristetraprolin, a protein that binds AREs and is known to be associated with the degradation of RNAs containing AREs. Prompted by this observation, we examined the status of the ARE binding proteins tristetraprolin and TIA-1/TIAR in infected cells. We report that tristetraprolin was made and accumulated in the cytoplasm of wild-type virus-infected human foreskin fibroblasts as early as 2 h and in HEp-2 cells as early as 6 h after infection. The amounts of tristetraprolin that accumulated in the cytoplasm of cells infected with a mutant virus lacking U(L)41 were significantly lower than those in wild-type virus-infected cells. The localization of tristetraprolin was not modified in cells infected with a mutant lacking the gene encoding infected cell protein 4 (ICP4). TIA-1 and TIAR are two other proteins that are associated with the regulation of ARE-containing RNAs and that normally reside in nuclei. In infected cells, they started to accumulate in the cytoplasm after 6 h of infection. In cells infected with the mutant virus lacking U(L)41, TIA-1/TIAR accumulated in the cytoplasm in granular structures reminiscent of stress granules in a significant percentage of the cells. In addition, an antibody to tristetraprolin coprecipitated the Vhs protein from lysates of cells late in infection. The results indicate that the Vhs-dependent degradation of ARE-containing RNAs correlates with the transactivation, cytoplasmic accumulation, and persistence of tristetraprolin in infected cells.
Herpes simplex virus 1 causes a shutoff of cellular protein synthesis through the degradation of RNA that is mediated by the virion host shutoff (Vhs) protein encoded by the U sub(L)41 gene. We reported elsewhere that the Vhs- dependent degradation of RNA is selective, and we identified RNAs containing AU- rich elements (AREs) that were upregulated after infection but degraded by deadenylation and progressive 3'-to-5' degradation. We also identified upregulated RNAs that were not subject to Vhs-dependent degradation (A. Esclatine, B. Taddeo, L. Evans, and B. Roizman, Proc. Natl. Acad. Sci. USA 101:3603-3608, 2004). Among the latter was the RNA encoding tristetraprolin, a protein that binds AREs and is known to be associated with the degradation of RNAs containing AREs. Prompted by this observation, we examined the status of the ARE binding proteins tristetraprolin and TIA-1/TIAR in infected cells. We report that tristetraprolin was made and accumulated in the cytoplasm of wild- type virus-infected human foreskin fibroblasts as early as 2 h and in HEp-2 cells as early as 6 h after infection. The amounts of tristetraprolin that accumulated in the cytoplasm of cells infected with a mutant virus lacking U sub(L)41 were significantly lower than those in wild-type virus-infected cells. The localization of tristetraprolin was not modified in cells infected with a mutant lacking the gene encoding infected cell protein 4 (ICP4). TIA-1 and TIAR are two other proteins that are associated with the regulation of ARE-containing RNAs and that normally reside in nuclei. In infected cells, they started to accumulate in the cytoplasm after 6 h of infection. In cells infected with the mutant virus lacking U sub(L)41, TIA-1/TIAR accumulated in the cytoplasm in granular structures reminiscent of stress granules in a significant percentage of the cells. In addition, an antibody to tristetraprolin coprecipitated the Vhs protein from lysates of cells late in infection. The results indicate that the Vhs-dependent degradation of ARE-containing RNAs correlates with the transactivation, cytoplasmic accumulation, and persistence of tristetraprolin in infected cells.
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
Author Audrey Esclatine
Brunella Taddeo
Bernard Roizman
AuthorAffiliation The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, Illinois 60637
AuthorAffiliation_xml – name: The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, Illinois 60637
Author_xml – sequence: 1
  givenname: Audrey
  surname: Esclatine
  fullname: Esclatine, Audrey
  organization: The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, Illinois 60637
– sequence: 2
  givenname: Brunella
  surname: Taddeo
  fullname: Taddeo, Brunella
  organization: The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, Illinois 60637
– sequence: 3
  givenname: Bernard
  surname: Roizman
  fullname: Roizman, Bernard
  organization: The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, Illinois 60637
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15998318$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15280467$$D View this record in MEDLINE/PubMed
BookMark eNqFks1u1DAUhS1URH_gFZCFBCsytR3HcRZUGoafDqoATacVO8txnMZVYgc7aRkekOfC0xmqgQX1wpauv3Psq3sOwZ51VgMAMZpgTPjxp8v5JOcTzCY84yThWUEmBCH6CBxgVPAkyzDdAwcIEZJkKf-2Dw5DuEYIU8roE7CPM8IRZfkB-HWqfa8DPDdd3-of8NL4MUAM57YaVazPVoPrWxk6o-BUqbEbWzkYZ6Gr4XI-TfBx3BdQ2gqWbmjg-coOjQ4m3JX-q_YmDHrwsveuNfY1XN46ONNtGxkPv3o3aGMDXDZygG9NNFsbvtNhkKVpzU8NpxfJwqgGLj5Pw1PwuJZt0M-25xG4-PB-OTtNzr58nM-mZ4nKUDokBGdlVjFFMl2iumYVyouUaMw1x5oXhVZxVZQSXZRU8pTpLGWI5BTluKSqTo_Am41vP5adrpS2sYFW9N500q-Ek0b8fWNNI67cjaB5gRiL-ldbvXffx9iM6ExQsWlptRuDYCyPs8P4QRBzhDhFJILPd390_5U_I47Ayy0gg5Jt7aVVJuxwRcFTzCN3suGUdyF4XQtlhrtpxUZMKzAS6-yJmD2Rc4GZWGdPrLMn1tmLBvwfg_s3Hpa-2Egbc9XcGq9FzIy4vjE7ePob3XTs2Q
CitedBy_id crossref_primary_10_1586_14789450_4_6_711
crossref_primary_10_3390_v13010017
crossref_primary_10_1073_pnas_0905828106
crossref_primary_10_1128_JVI_00975_10
crossref_primary_10_3390_ijms23147836
crossref_primary_10_1371_journal_pone_0016958
crossref_primary_10_1073_pnas_1305475110
crossref_primary_10_1128_JVI_01557_12
crossref_primary_10_1099_jgv_0_001976
crossref_primary_10_1038_cgt_2008_40
crossref_primary_10_1292_jvms_10_0059
crossref_primary_10_1038_ni1266
crossref_primary_10_1128_JVI_79_1_472_485_2005
crossref_primary_10_1016_j_molimm_2021_10_015
crossref_primary_10_1128_JVI_00137_08
crossref_primary_10_3390_v8030081
crossref_primary_10_1128_JVI_01812_06
crossref_primary_10_1128_JVI_80_1_505_513_2006
crossref_primary_10_3390_v8070180
crossref_primary_10_1016_j_bbi_2010_04_006
crossref_primary_10_1016_j_vetmic_2022_109494
crossref_primary_10_1128_JVI_00115_11
crossref_primary_10_1128_JVI_01239_09
crossref_primary_10_1096_fba_2024_00022
crossref_primary_10_1128_JVI_01819_09
crossref_primary_10_1038_nrm1834
crossref_primary_10_3390_v11060563
crossref_primary_10_1091_mbc_e05_02_0124
crossref_primary_10_1038_onc_2011_120
crossref_primary_10_1128_JVI_01554_14
crossref_primary_10_1371_journal_ppat_1004659
crossref_primary_10_1371_journal_ppat_1004899
crossref_primary_10_1128_JVI_00313_12
crossref_primary_10_1128_JVI_00829_18
crossref_primary_10_1128_JVI_01779_07
crossref_primary_10_1016_j_brainres_2012_02_032
crossref_primary_10_1111_j_1462_5822_2007_00951_x
crossref_primary_10_1126_sciadv_adl5638
crossref_primary_10_1128_JVI_00587_06
crossref_primary_10_1128_mBio_00960_19
crossref_primary_10_1128_JVI_00886_09
crossref_primary_10_1073_pnas_0705245104
crossref_primary_10_1128_JVI_02041_19
crossref_primary_10_1002_wrna_1188
crossref_primary_10_1016_j_tibs_2007_12_003
crossref_primary_10_1016_j_virusres_2012_06_004
crossref_primary_10_1128_jvi_02086_21
crossref_primary_10_1073_pnas_0510712103
crossref_primary_10_1089_jir_2013_0143
crossref_primary_10_3390_v6093500
crossref_primary_10_1371_journal_ppat_1008111
crossref_primary_10_1042_BST0320697
crossref_primary_10_1128_JVI_01302_16
crossref_primary_10_1128_JVI_03180_15
crossref_primary_10_1002_wrna_23
crossref_primary_10_1128_JVI_79_7_4090_4098_2005
crossref_primary_10_1186_1742_4690_5_47
crossref_primary_10_1371_journal_pgen_1002474
crossref_primary_10_1146_annurev_virology_100114_054839
crossref_primary_10_1016_j_heliyon_2016_e00159
crossref_primary_10_1128_JVI_00947_16
crossref_primary_10_1016_j_cellsig_2010_08_011
crossref_primary_10_1128_JVI_00091_15
crossref_primary_10_1128_JVI_02603_13
crossref_primary_10_1128_JVI_00005_13
Cites_doi 10.1128/JVI.77.3.2038-2045.2003
10.1016/S0021-9258(17)46259-4
10.1073/pnas.1533420100
10.1093/emboj/19.15.4154
10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2
10.1042/bst0300945
10.1073/pnas.2034952100
10.1074/jbc.M206505200
10.1042/bst0300963
10.1128/JVI.77.12.7101-7105.2003
10.4049/jimmunol.152.10.4937
10.1038/sj.onc.1204061
10.1074/jbc.274.4.2322
10.1016/S0092-8674(01)00578-5
10.1073/pnas.92.23.10516
10.1128/JVI.77.11.6178-6187.2003
10.1128/JVI.74.16.7307-7319.2000
10.1099/0022-1317-2-3-357
10.1002/jcp.10272
10.1128/jvi.71.12.9188-9197.1997
10.1128/JVI.75.21.10272-10280.2001
10.1073/pnas.96.21.12062
10.1242/jcs.115.16.3227
10.1006/viro.1999.9986
10.1073/pnas.94.3.843
10.1074/jbc.M300016200
10.1128/JVI.74.17.7842-7850.2000
10.1073/pnas.252588599
10.1038/sj.onc.1206418
10.1128/jvi.69.1.403-413.1995
10.1073/pnas.0400354101
10.1128/JVI.74.22.10816-10818.2000
10.1126/science.281.5379.1001
10.1128/MCB.15.10.5777
10.1128/MCB.23.11.3798-3812.2003
10.1186/ar797
10.1074/jbc.M304856200
10.1073/pnas.92.5.1629
10.1073/pnas.84.7.1926
10.1093/emboj/20.5.1134
10.1128/jvi.46.2.498-512.1983
10.1128/jvi.62.3.912-921.1988
10.1083/jcb.147.7.1431
10.1128/JVI.78.3.1063-1068.2004
ContentType Journal Article
Copyright 2004 INIST-CNRS
Copyright © 2004, American Society for Microbiology 2004
Copyright_xml – notice: 2004 INIST-CNRS
– notice: Copyright © 2004, American Society for Microbiology 2004
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7U9
H94
7X8
5PM
DOI 10.1128/JVI.78.16.8582-8592.2004
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nucleic Acids Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
EndPage 8592
ExternalDocumentID PMC479066
15280467
15998318
10_1128_JVI_78_16_8582_8592_2004
jvi_78_16_8582
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA71933
– fundername: NCI NIH HHS
  grantid: R01 CA078766
– fundername: NCI NIH HHS
  grantid: CA83939
– fundername: NCI NIH HHS
  grantid: CA78766
– fundername: NCI NIH HHS
  grantid: P01 CA087661
– fundername: NCI NIH HHS
  grantid: R01 CA088860
– fundername: NCI NIH HHS
  grantid: CA88860
– fundername: NCI NIH HHS
  grantid: R37 CA078766
– fundername: NCI NIH HHS
  grantid: R01 CA083939
– fundername: NCI NIH HHS
  grantid: CA87661
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
29L
2WC
39C
3O-
4.4
53G
5GY
5RE
5VS
85S
AAFWJ
AAGFI
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AFFNX
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
MVM
N9A
O9-
OHT
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
VH1
W2D
W8F
WH7
WOQ
X7M
Y6R
YQT
ZGI
~02
~KM
41~
6TJ
AAYJJ
ADXHL
D0S
IQODW
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
PKN
RHF
UCJ
7TM
7U9
H94
7X8
5PM
ID FETCH-LOGICAL-c503t-215b5d6c25eb0ff6d07932e18e81e899eccccd442e9b4a836e5360274071b4cf3
ISSN 0022-538X
IngestDate Thu Aug 21 14:13:31 EDT 2025
Thu Jul 10 22:40:22 EDT 2025
Fri Jul 11 09:19:29 EDT 2025
Wed Feb 19 01:54:36 EST 2025
Mon Jul 21 09:14:53 EDT 2025
Tue Jul 01 00:56:43 EDT 2025
Thu Apr 24 23:07:21 EDT 2025
Wed May 18 15:31:24 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 16
Keywords Microbiology
RNA
Herpesviridae
Alphaherpesvirinae
Herpes
Protein
Virology
Infection
Virus
Synthesis
Viral disease
Human herpesvirus 1
Herpesvirus hominis
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c503t-215b5d6c25eb0ff6d07932e18e81e899eccccd442e9b4a836e5360274071b4cf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: The Marjorie B. Kovler Viral Oncology Labs, The University of Chicago, 910 E. 58th St., Chicago, IL 60637. Phone: (773) 702-1898. Fax: (773) 702-1651. E-mail: Bernard.Roizman@bsd.uchicago.edu.
OpenAccessLink http://doi.org/10.1128/JVI.78.16.8582-8592.2004
PMID 15280467
PQID 18008402
PQPubID 23462
PageCount 11
ParticipantIDs proquest_miscellaneous_18008402
pascalfrancis_primary_15998318
crossref_citationtrail_10_1128_JVI_78_16_8582_8592_2004
proquest_miscellaneous_66755111
crossref_primary_10_1128_JVI_78_16_8582_8592_2004
highwire_asm_jvi_78_16_8582
pubmedcentral_primary_oai_pubmedcentral_nih_gov_479066
pubmed_primary_15280467
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-08-01
PublicationDateYYYYMMDD 2004-08-01
PublicationDate_xml – month: 08
  year: 2004
  text: 2004-08-01
  day: 01
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Journal of Virology
PublicationTitleAlternate J Virol
PublicationYear 2004
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
(e_1_3_2_25_2) 1994; 152
e_1_3_2_30_2
(e_1_3_2_36_2) 1997; 229
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
(e_1_3_2_46_2) 1996; 10
6302315 - J Virol. 1983 May;46(2):498-512
11581395 - J Virol. 2001 Nov;75(21):10272-80
12789264 - Oncogene. 2003 Jun 5;22(23):3554-61
2204625 - J Biol Chem. 1990 Sep 25;265(27):16556-63
7565731 - Mol Cell Biol. 1995 Oct;15(10):5777-88
10518576 - Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12062-7
11719186 - Cell. 2001 Nov 16;107(4):451-64
12748283 - Mol Cell Biol. 2003 Jun;23(11):3798-812
11044129 - J Virol. 2000 Nov;74(22):10816-8
10544145 - Virology. 1999 Nov 10;264(1):195-204
7533298 - Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1629-33
2828686 - J Virol. 1988 Mar;62(3):912-21
10906184 - J Virol. 2000 Aug;74(16):7307-19
9371577 - J Virol. 1997 Dec;71(12):9188-97
12380690 - Cell Stress Chaperones. 2002 Apr;7(2):213-21
11244505 - Oncogene. 2001 Jan 4;20(1):69-76
9703499 - Science. 1998 Aug 14;281(5379):1001-5
12525638 - J Virol. 2003 Feb;77(3):2038-45
10921895 - EMBO J. 2000 Aug 1;19(15):4154-63
12440952 - Biochem Soc Trans. 2002 Nov;30(Pt 6):945-52
9890998 - J Biol Chem. 1999 Jan 22;274(4):2322-6
7983736 - J Virol. 1995 Jan;69(1):403-13
12440955 - Biochem Soc Trans. 2002 Nov;30(Pt 6):963-9
12823857 - Arthritis Res Ther. 2003;5(4):R214-25
12855769 - Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8963-8
14993598 - Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3603-8
4300104 - J Gen Virol. 1968 May;2(3):357-64
10933691 - J Virol. 2000 Sep;74(17):7842-50
8825554 - Mol Endocrinol. 1996 Feb;10(2):140-6
3031658 - Proc Natl Acad Sci U S A. 1987 Apr;84(7):1926-30
12704645 - J Cell Physiol. 2003 Jun;195(3):356-72
14530405 - Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12408-13
7479831 - Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10516-20
9023344 - Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8
10613902 - J Cell Biol. 1999 Dec 27;147(7):1431-42
8176212 - J Immunol. 1994 May 15;152(10):4937-45
9123882 - Virology. 1997 Mar 3;229(1):98-105
12140254 - J Cell Sci. 2002 Aug 15;115(Pt 16):3227-34
12754205 - J Biol Chem. 2003 Aug 8;278(32):30373-81
12481033 - Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17031-6
12743274 - J Virol. 2003 Jun;77(11):6178-87
12324455 - J Biol Chem. 2002 Dec 13;277(50):48558-64
14722261 - J Virol. 2004 Feb;78(3):1063-8
12768029 - J Virol. 2003 Jun;77(12):7101-5
11230136 - EMBO J. 2001 Mar 1;20(5):1134-43
12578839 - J Biol Chem. 2003 Apr 18;278(16):13928-35
References_xml – ident: e_1_3_2_33_2
  doi: 10.1128/JVI.77.3.2038-2045.2003
– ident: e_1_3_2_32_2
  doi: 10.1016/S0021-9258(17)46259-4
– ident: e_1_3_2_20_2
  doi: 10.1073/pnas.1533420100
– ident: e_1_3_2_35_2
  doi: 10.1093/emboj/19.15.4154
– ident: e_1_3_2_4_2
  doi: 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2
– ident: e_1_3_2_7_2
  doi: 10.1042/bst0300945
– ident: e_1_3_2_44_2
  doi: 10.1073/pnas.2034952100
– ident: e_1_3_2_47_2
  doi: 10.1074/jbc.M206505200
– ident: e_1_3_2_26_2
  doi: 10.1042/bst0300963
– ident: e_1_3_2_10_2
  doi: 10.1128/JVI.77.12.7101-7105.2003
– volume: 152
  start-page: 4937
  year: 1994
  ident: e_1_3_2_25_2
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.152.10.4937
– ident: e_1_3_2_5_2
  doi: 10.1038/sj.onc.1204061
– ident: e_1_3_2_21_2
  doi: 10.1074/jbc.274.4.2322
– ident: e_1_3_2_11_2
  doi: 10.1016/S0092-8674(01)00578-5
– ident: e_1_3_2_13_2
  doi: 10.1073/pnas.92.23.10516
– ident: e_1_3_2_43_2
  doi: 10.1128/JVI.77.11.6178-6187.2003
– ident: e_1_3_2_15_2
  doi: 10.1128/JVI.74.16.7307-7319.2000
– ident: e_1_3_2_14_2
  doi: 10.1099/0022-1317-2-3-357
– ident: e_1_3_2_6_2
  doi: 10.1002/jcp.10272
– ident: e_1_3_2_40_2
  doi: 10.1128/jvi.71.12.9188-9197.1997
– ident: e_1_3_2_18_2
  doi: 10.1128/JVI.75.21.10272-10280.2001
– ident: e_1_3_2_28_2
  doi: 10.1073/pnas.96.21.12062
– ident: e_1_3_2_3_2
  doi: 10.1242/jcs.115.16.3227
– ident: e_1_3_2_24_2
  doi: 10.1006/viro.1999.9986
– ident: e_1_3_2_22_2
  doi: 10.1073/pnas.94.3.843
– ident: e_1_3_2_38_2
  doi: 10.1074/jbc.M300016200
– ident: e_1_3_2_2_2
  doi: 10.1128/JVI.74.17.7842-7850.2000
– ident: e_1_3_2_42_2
  doi: 10.1073/pnas.252588599
– ident: e_1_3_2_41_2
  doi: 10.1038/sj.onc.1206418
– ident: e_1_3_2_23_2
  doi: 10.1128/jvi.69.1.403-413.1995
– ident: e_1_3_2_16_2
  doi: 10.1073/pnas.0400354101
– ident: e_1_3_2_8_2
  doi: 10.1128/JVI.74.22.10816-10818.2000
– ident: e_1_3_2_9_2
  doi: 10.1126/science.281.5379.1001
– ident: e_1_3_2_12_2
  doi: 10.1128/MCB.15.10.5777
– ident: e_1_3_2_31_2
  doi: 10.1128/MCB.23.11.3798-3812.2003
– volume: 10
  start-page: 140
  year: 1996
  ident: e_1_3_2_46_2
  publication-title: Mol. Endocrinol.
– ident: e_1_3_2_17_2
  doi: 10.1186/ar797
– ident: e_1_3_2_34_2
  doi: 10.1074/jbc.M304856200
– ident: e_1_3_2_45_2
  doi: 10.1073/pnas.92.5.1629
– ident: e_1_3_2_29_2
  doi: 10.1073/pnas.84.7.1926
– ident: e_1_3_2_19_2
  doi: 10.1093/emboj/20.5.1134
– ident: e_1_3_2_37_2
  doi: 10.1128/jvi.46.2.498-512.1983
– ident: e_1_3_2_30_2
  doi: 10.1128/jvi.62.3.912-921.1988
– volume: 229
  start-page: 98
  year: 1997
  ident: e_1_3_2_36_2
  publication-title: 5 genes of herpes simplex virus 1. Virology
– ident: e_1_3_2_27_2
  doi: 10.1083/jcb.147.7.1431
– ident: e_1_3_2_39_2
  doi: 10.1128/JVI.78.3.1063-1068.2004
– reference: 4300104 - J Gen Virol. 1968 May;2(3):357-64
– reference: 10906184 - J Virol. 2000 Aug;74(16):7307-19
– reference: 12748283 - Mol Cell Biol. 2003 Jun;23(11):3798-812
– reference: 12380690 - Cell Stress Chaperones. 2002 Apr;7(2):213-21
– reference: 12440955 - Biochem Soc Trans. 2002 Nov;30(Pt 6):963-9
– reference: 12768029 - J Virol. 2003 Jun;77(12):7101-5
– reference: 3031658 - Proc Natl Acad Sci U S A. 1987 Apr;84(7):1926-30
– reference: 8825554 - Mol Endocrinol. 1996 Feb;10(2):140-6
– reference: 2828686 - J Virol. 1988 Mar;62(3):912-21
– reference: 8176212 - J Immunol. 1994 May 15;152(10):4937-45
– reference: 11230136 - EMBO J. 2001 Mar 1;20(5):1134-43
– reference: 7983736 - J Virol. 1995 Jan;69(1):403-13
– reference: 11244505 - Oncogene. 2001 Jan 4;20(1):69-76
– reference: 7565731 - Mol Cell Biol. 1995 Oct;15(10):5777-88
– reference: 11581395 - J Virol. 2001 Nov;75(21):10272-80
– reference: 12140254 - J Cell Sci. 2002 Aug 15;115(Pt 16):3227-34
– reference: 14530405 - Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12408-13
– reference: 12578839 - J Biol Chem. 2003 Apr 18;278(16):13928-35
– reference: 12704645 - J Cell Physiol. 2003 Jun;195(3):356-72
– reference: 9703499 - Science. 1998 Aug 14;281(5379):1001-5
– reference: 10544145 - Virology. 1999 Nov 10;264(1):195-204
– reference: 11719186 - Cell. 2001 Nov 16;107(4):451-64
– reference: 9371577 - J Virol. 1997 Dec;71(12):9188-97
– reference: 10613902 - J Cell Biol. 1999 Dec 27;147(7):1431-42
– reference: 6302315 - J Virol. 1983 May;46(2):498-512
– reference: 12754205 - J Biol Chem. 2003 Aug 8;278(32):30373-81
– reference: 9023344 - Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8
– reference: 12855769 - Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8963-8
– reference: 12324455 - J Biol Chem. 2002 Dec 13;277(50):48558-64
– reference: 10518576 - Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12062-7
– reference: 14993598 - Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3603-8
– reference: 7533298 - Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1629-33
– reference: 10933691 - J Virol. 2000 Sep;74(17):7842-50
– reference: 12823857 - Arthritis Res Ther. 2003;5(4):R214-25
– reference: 9123882 - Virology. 1997 Mar 3;229(1):98-105
– reference: 12440952 - Biochem Soc Trans. 2002 Nov;30(Pt 6):945-52
– reference: 12743274 - J Virol. 2003 Jun;77(11):6178-87
– reference: 11044129 - J Virol. 2000 Nov;74(22):10816-8
– reference: 12481033 - Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17031-6
– reference: 7479831 - Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10516-20
– reference: 12789264 - Oncogene. 2003 Jun 5;22(23):3554-61
– reference: 10921895 - EMBO J. 2000 Aug 1;19(15):4154-63
– reference: 2204625 - J Biol Chem. 1990 Sep 25;265(27):16556-63
– reference: 14722261 - J Virol. 2004 Feb;78(3):1063-8
– reference: 9890998 - J Biol Chem. 1999 Jan 22;274(4):2322-6
– reference: 12525638 - J Virol. 2003 Feb;77(3):2038-45
SSID ssj0014464
Score 2.061433
Snippet Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
Herpes simplex virus 1 causes a shutoff of cellular protein synthesis through the degradation of RNA that is mediated by the virion host shutoff (Vhs) protein...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 8582
SubjectTerms Biological and medical sciences
Cell Line, Tumor
Cells, Cultured
Cytoplasm - metabolism
DNA-Binding Proteins
Fibroblasts - virology
Fundamental and applied biological sciences. Psychology
HeLa Cells
Herpes simplex virus 1
Herpesvirus 1, Human - pathogenicity
Human viral diseases
Humans
Immediate-Early Proteins - genetics
Immediate-Early Proteins - metabolism
Infectious diseases
Medical sciences
Microbiology
Miscellaneous
Poly(A)-Binding Proteins
Proteins - genetics
Proteins - metabolism
Ribonucleases
RNA, Messenger - genetics
RNA, Messenger - metabolism
RNA-Binding Proteins - genetics
RNA-Binding Proteins - metabolism
T-Cell Intracellular Antigen-1
Tristetraprolin
Up-Regulation
Viral diseases
Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye
Viral Proteins - metabolism
Virology
Virus-Cell Interactions
Title Herpes Simplex Virus 1 Induces Cytoplasmic Accumulation of TIA-1/TIAR and both Synthesis and Cytoplasmic Accumulation of Tristetraprolin, Two Cellular Proteins That Bind and Destabilize AU-Rich RNAs
URI http://jvi.asm.org/content/78/16/8582.abstract
https://www.ncbi.nlm.nih.gov/pubmed/15280467
https://www.proquest.com/docview/18008402
https://www.proquest.com/docview/66755111
https://pubmed.ncbi.nlm.nih.gov/PMC479066
Volume 78
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKEBIviP-UwfADbyFdkziO81jQpm0aQ5pa1DcrcRy1CJqqSQbbN-KL8Lm4c_40HdsYvKSVYztR7pfz3eX8O0LepqmIvCT2bB753GaKKTtOUm7zFMyNGAxcbeqQfTzhBxN2NPWnvd7PTtZSWcQDdXHlvpL_kSq0gVxxl-w_SLadFBrgP8gXjiBhON5Kxgd6tdS5lc-R4veHdTZflbnlWOBml5hopc6LbAnWMaa_R0qV3-pSXWggjg9HNiox-D01HxDiDHPVzxdgECJHidnudsP4ApWDLlbR0pT9QUkV3zMLvwOYxFbD_4DpN8UsKixwvw0lrJXAImQ4fS-0NZrYoIRn1unJKL_GRsZNeN2w_16u8BbqKGyZrHR7aowqNKvhirk77Xpzms0v6jjve4x-VjQCbaiDtYl23a0HoKGnXfUdiC5Mu8pY-FVdoz9XCRd3Phx9PhwEYuDwAXa0hR8aYlK2XhmbbICTT3J_cnwsx3vT8R1y1wWPxGsCQ_UHK_CqWUNMj3fYJI25Yve662xaQg07NSbnRjm8n2lVWOUqz-dyAm_HIho_JA9qMdFRhctHpKcXj8m9qrjp-RPyq0InrdFJDTqpQ2t00g66aBddNEupQecuYpMCaihik7bYNE03jb6EzXcUkEkbZNIGmRSRSRGZZsIOMmmNTIrIfEom-3vjDwd2XTXEVv7QK2ywYWM_4cr1dTxMU54gBaSrHaGFo0UYgs5SKmHM1WHMIuGBNvI4BmfA2I6ZSr1nZGuRLfQLkKAOdRoLwbzIY0kYi1hFigXDQLlRxD3VJ0EjQalqSn2s7PJVGtfaFRJkLwMhHS5R9hJlj4VfWZ847chlRStzizHbDUgkPF755Wze6dcnOxu4WU_rh6GAlbtP3jRAkrCE4FOPFjorc-kIrKoxdK_vwXkAnpXj9MnzCnid2V0xBGOrT_gGJNsOSF-_eWYxnxkaexaE4O-8_OtFt8n9tTJ4RbaKValfgydQxDvmHfwN_NgSNw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Herpes+simplex+virus+1+induces+cytoplasmic+accumulation+of+TIA-1%2FTIAR+and+both+synthesis+and+cytoplasmic+accumulation+of+tristetraprolin%2C+two+cellular+proteins+that+bind+and+destabilize+AU-rich+RNAs&rft.jtitle=Journal+of+virology&rft.au=Esclatine%2C+Audrey&rft.au=Taddeo%2C+Brunella&rft.au=Roizman%2C+Bernard&rft.date=2004-08-01&rft.issn=0022-538X&rft.volume=78&rft.issue=16&rft.spage=8582&rft_id=info:doi/10.1128%2FJVI.78.16.8582-8592.2004&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon